肝素诱导性血小板减少症免疫检测的动态范围
基于1393例疑似肝素诱导性血小板减少症(HIT)患者的前瞻性研究数据,评估两种肝素/血小板因子4免疫检测在其动态范围内的诊断意义,并以洗涤血小板肝素诱导血小板活化试验为诊断标准。HIT患病率为8.5%(n=119),两种检测的似然比随动态范围升高而增大,但关联强度因检测方法而异,CLIA每单位增幅更大,并提供了基于网页计算器的个体化验后概率估算。
要点
- HIT患病率为8.5%(n=119),诊断以洗涤血小板肝素诱导血小板活化试验为准。
- CLIA在动态范围0.3%(0.4 U/mL)时似然比首次≥10,ELISA在16%(0.64光密度)时首次≥10。
- CLIA在动态范围9.4%(12 U/mL)时似然比≥100,ELISA在75.0%(3.0光密度)时≥100。
核心结论
- 两种免疫检测结果均与诊断意义相关,但关联强度因检测方法而异,CLIA每测量单位增幅更大。
- 个体患者的验后概率可使用网页计算器估算:https://pcd-research.shinyapps.io/BayesianCalculator/
研究设计与样本
- 研究利用「towards precise and rapid diagnosis of heparin-induced thrombocytopenia」前瞻性研究数据,纳入1393例连续疑似HIT患者。
- 评估两种肝素/血小板因子4免疫检测在其各自动态范围内的诊断意义:HemoSil Acustar HIT IgG(化学发光免疫分析,CLIA)和Lifecodes PF4免疫球蛋白G(酶联免疫吸附试验,ELISA)。
- HIT诊断由洗涤血小板肝素诱导血小板活化试验确定;对数据集中每个测量点计算似然比、灵敏度和特异度,并计算区间特异性似然比以提供个体检测结果的验后概率。
主要发现
- HIT患病率为8.5%(n=119)。
- 似然比≥10首次出现于动态范围0.3%(0.4 U/mL;CLIA)和16%(0.64光密度;ELISA)。
- 似然比≥100出现于动态范围9.4%(12 U/mL;CLIA)和75.0%(3.0光密度;ELISA)。
- 线性回归线(似然比~动态范围)的斜率为9.5(CLIA)和0.9(ELISA)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following the current guidelines, immunoassays for the diagnosis of heparin-induced thrombocytopenia (HIT) are interpreted dichotomously, with test results categorized as either positive or negative. However, the extent to which test results hold diagnostic significance across the entire dynamic range remains unclear. OBJECTIVES: We utilized data from the prospective towards precise and rapid diagnosis of heparin-induced thrombocytopenia study, comprising 1393 consecutive patients with suspected HIT, to assess the diagnostic significance of 2 heparin/platelet factor 4 immunoassay test results across their respective dynamic ranges: HemoSil Acustar HIT IgG (chemiluminescence immunoassay [CLIA]) and Lifecodes PF4 immunoglobulin G (enzyme-linked immunosorbent assay [ELISA]). METHODS: HIT diagnosis was determined by a washed platelet heparin-induced platelet activation assay. For each measurement point in the dataset, we computed likelihood ratios (LRs), sensitivities, and specificities. To provide posttest probabilities for individual test results, we calculated interval-specific LRs and integrated them into a web-based calculator. RESULTS: The prevalence of HIT was 8.5% (n = 119). An LR of ≥10 was first achieved at 0.3% of the dynamic range (0.4 U/mL; CLIA) and then at 16% (0.64 optical density; ELISA). An LR of ≥100 was present at 9.4% (12 U/mL; CLIA) and 75.0% (3.0 optical density; ELISA). The slope of the linear regression line (LR ∼ dynamic range) was 9.5 (CLIA) and 0.9 (ELISA). CONCLUSION: Despite both immunoassays showing an association between results and diagnostic significance, the strength of the association varies by assay. CLIA has a larger increase per measurement unit. Posttest probabilities for individual patients can be estimated using a web-based calculator: https://pcd-research.shinyapps.io/BayesianCalculator/.
引用
- Nilius H, Naas S, Studt JD, et al. The dynamic range of immunoassays for heparin-induced thrombocytopenia. J Thromb Haemost. 2024. PMID: 39536820. doi:10.1016/j.jtha.2024.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。